Dose-ranging study in younger adult and elderly patients of ORG 9487, a new, rapid-onset, short-duration muscle relaxant

Anesthesia and Analgesia

Volumn 84, Issue 5, 1997, Pages 1011-1018

  Kahwaji, Raymond ^a   Bevan, David R ^a   Bikhazi, George ^b   Shanks, Colin A ^c   Fragen, Robert J ^c   Dyck, J Barry ^d   Angst, M S ^d   Matteo, Richard ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OXYGEN; PROPOFOL; RAPACURONIUM BROMIDE; THIOPENTAL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ELECTROMYOGRAM; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030910025     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199705000-00011     Document Type: Article

References (24)

1. Wierda JM, Beaufort AM, Kleef UW, et al. Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487. Can J Anaesth 1994;41:213-20.
2. Wierda JM, van den Broek L, Proost JH, et al. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant: a comparison with succinylcholine. Anesth Analg 1993;77:579-84.
3. Van den Broek L, Wierda JM, Smeulers NJ, Proost JH. Pharmacodynamics and pharmacokinetics of an infusion of Org 9487, a new short-acting steroidal neuromuscular blocking agent. Br J Anaesth 1994;73:331-5.
4. Bedford RE. From the FDA [abstract]. Anesthesiology 1995;82: 33A.
5. Katz RL, Norman J, Seed RF, Conrad L. A comparison of the effects of suxamethonium and tubocurarine in patients in London and New York. Br J Anaesth 1969;41:1041-7.
6. Fiset P, Donati F, Balendran P, et al. Vecuronium is more potent in Montréal than in Paris. Can J Anaesth 1991;38:717-21.
7. Duvaldestin P, Saada J, Berger JL, et al. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 1982;56: 36-40.
8. D'Hollander AA, Nevelsteen M, Barvais L. Paralysis induced in anaesthetized adult subjects by ORG NC 45. Acta Anaesthesiol Scand 1983;27:108-10.
9. Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 1993;77:1193-7.
10. Mirakhur RK, Lavery GG, Clarke RSJ, et al. Atracurium in clinical anaesthesia: effect of dosage on onset, duration and conditions for tracheal intubation. Anaesthesia 1985;40:801-5.
11. Lien CA, Schmith VD, Belmont MR, et al. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 1996;84:300-8.
12. Sohn YJ, Bencini AF, Scaf AHJ, et al. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients. Anesth Analg 1986;65:233-9.
13. Wierda JMKH, de Wit APM, Kuizenga K, Agoston S. Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal non-depolarizing agent. Br J Anaesth 1990;64:521-3.
14. Bartkowski RR, Witkowski TA, Azad S, et al. Rocuronium onset of action: a comparison with atracurium and vecuronium. Anesth Analg 1993;77:574-8.
15. Pühringer FK, Khuenl-Brady KS, Koller J, Mitterschiffthaler G. Evaluation of the endotracheal intubating conditions of rocuronium (Org 9426) and succinylcholine in outpatient surgery. Anesth Analg 1992;75:37-40.
16. Cooper R, Mirakhur RK, Clarke RSJ, Boules Z. Comparison of intubating conditions after administration of ORG 9426 (rocuronium) and suxamethonium. Br J Anaesth 1992;69:269-73.
17. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 1993;79: 913-8.
18. Law Min JC, Bekavac I, Glavinovic MI, et al. Iontophoretic study of speed of action of various muscle relaxants. Anesthesiology 1992;77:351-6.
19. Kopman AF. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency? Anesthesiology 1989;70:915-20.
20. Donati F. Onset of action of relaxants. Can J Anaesth 1988;35: S52-8.
21. Viby-Mogensen J, Engbæk J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40: 59-74.
22. McCoy EP, Mirakhur RK, Conolly FM, Loan PB. The influence of the duration of control stimulation on the onset and recovery of neuromuscular block. Anesth Analg 1995;80:364-7.
23. Muir AW, Houston J, Green KL, et al. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 1989;63:400-10.
24. Stoelting RK. The hemodynamic effects of pancuronium and d-tubocurarine in anesthetized patients. Anesthesiology 1972; 36:612-5.